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resumo 
 
 
Um dos grandes desafios da engenharia de tecidos (TE) vasculares, 
prende-se com a pouca disponibilidade de tecidos vasculares autólogos 
para substituição de vasos sanguíneos de pequeno diâmetro (<6 mm). 
Estudos demonstram que o poliuretano possui propriedades mecânicas 
adequadas para a utilização em vasos sanguíneos de pequenos 
diâmetros. Trabalhos anteriores realçam as propriedades 
antibacterianas de compósitos compostos por PU e nanopartículas de 
oxido de zinco (nZnO). 
O presente estudo teve como objetivo a produção de membranas 
compósitas de PU/ nZnO com recurso a electrofiação. Mais 
concretamente pretendia-se avaliar as propriedades antibacterianas e 
mecânicas dos compósitos, testando diferentes concentrações de nZnO. 
Foram sintetizadas nanopartículas de óxido de zinco, através do método 
de precipitação química à temperatura ambiente, obtendo-se nano 
estruturas porosas. As membranas compósitas foram testadas contra 
E.coli e S.aureus evidenciando um bom comportamento antibacteriano, 
bem como uma relação do mesmo com a concentração de nZnO nas 
membranas. No que diz respeito aos ensaios mecânicos, as membranas 
mostraram boas propriedades. 
Em conclusão, as nZnO podem ser adicionas ao PU formando uma 
membrana com propriedades antibacterianas e boas propriedades 
mecânicas. 
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abstract 
 
 
One of the great challenges of vascular tissue engineering (TE) is the 
lack of availability of autologous vascular tissues to replace small-
diameter (<6 mm) blood vessels. Studies have shown that polyurethane 
has mechanical properties suitable for use in blood vessels of small 
diameters. Previous papers highlight the antibacterial properties of 
composites composed of PU and nanoparticles of zinc oxide (nZnO). 
The present study had as objective the production of composite 
membranes of PU / nZnO with the use of electrofying. More specifically, 
it was intended to evaluate the antibacterial and mechanical properties 
of the composites by testing different concentrations of nZnO. 
Nanoparticles of zinc oxide were synthesized through the chemical 
precipitation method at room temperature, obtaining nano porous 
structures. The composite membranes were tested against E. coli and 
S. aureus showing a good antibacterial behavior, as well as a relation 
thereof with the concentration of nZnO in the membranes. With regard 
to mechanical tests, the membranes showed good properties. 
In conclusion, the nZnO can be added to the PU forming a membrane 
with antibacterial properties and good mechanical properties. 
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CHAPTER I – CONTEXT AND OBJECTIVES 
 
 
1.1. Context 
Vascular diseases are an important issue in modern times, being the number one 
cause of death, responsible for more than 17 million deaths worldwide [1] , resulting in an 
estimated cost of almost 196 billion euros a year in EU alone [2]. In Portugal, according to 
the Sistema Nacional de Saúde (SNS), vascular diseases account for 29.5% of the deaths 
recorded in 2013. 
Therapies applied in clinical practice for treatment of vascular diseases include the 
transplantation of native autologous grafts, such as the saphenous vein or the internal 
mammary artery, the implantation of artificial grafts or the insertion of stents [3], [4]. 
However these clinical practices suffer from limitations. Although the use of autologous 
grafts shows good results, there is a lack of availability while inconvenient surgical 
harvesting and tissue graft preparation is required [3]. 
In case of donor grafts, the disadvantages are the shortage of available donors, the 
risk of pathogen transfer and rejection, and mandatory lifelong immunosuppressive 
therapies. Prostheses or devices re unable to completely restore the natural functions, 
often leading to unphysiological conditions which require permanent anticoagulation 
therapies [4]–[7] 
Therefore, there is an urgent need to develop functional small diameter vascular 
grafts to replace diseased or narrowed blood vessels [8], [9]. 
The development of vascular bioengineering has led to a variety of novel treatment 
strategies for patients with cardiovascular diseases and today’s major effort is focused on 
developing small diameter vascular grafts [10]. One of the strategic purposes of tissue 
engineering is to develop alternative materials that integrate with the patient’s native 
tissue to restore its lost physiologic function. 
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1.2. Objectives 
The present dissertation aims to develop PU/nZnO composites for vascular related 
diseases, to study its antibacterial behavior, as well as their mechanical properties. In this 
context, it is specifically intended to: 
I. Synthesize zinc oxide nanoparticles (nZnO) with different characteristics by a 
chemical precipitation method at room temperature. 
II. Optimization of the electrospinning parameters for the production of PU 
membranes 
III. Produce PU/nZnO composite meshes by combining both components in 
different percentages 
IV. Study the antibacterial behaviour of the PU/ZnO composites, trying to 
understand the impact of nZnO concentration on its bacterial response. A 
Gram-negative bacteria strain Escherichia coli (E.Coli) and a Gram-positive 
strain Staphylococcus aureus (S.Aureus) were tested. 
V. Study the mechanical properties of the composite membranes, evaluating the 
effect of ZnO concentration on the membranes tensile strenght. 
 
This dissertation is organized in five chapters.  
The first chapter describes the context and the main goal of this work. 
Chapter II is the State of the Art review, where the main problem proposed for this 
dissertation is addressed and a short review is made of the methods used to produce this 
type of membranes. 
Material and Methods of the all work performed is presented in Chapter III.  
Chapter IV presents all the results and discussion of the work. Finally, in the last 
chapter, the main findings of this dissertation and references to future prospects and 
possible improvements of this work are presented.  
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CHAPTER II – STATE OF THE ART 
 
2.1. Blood Vessel Structure  
 Blood vessels present a complex structure which includes three different 
concentric layers, i.e. intima, media and adventitia, each of them with a different 
composition and function. 
(1) Intima, the innermost layer, consists mainly of endothelial cells (ECs). It controls 
the molecular transfer inside the wall, providing antihormbogenicity. It is involved in 
homeostasis maintenance, muscular tone and immunogenic regulation; 
(2) Media, the middle layer is composed mainly of circumferentially arranged layers of 
smooth muscle cells (SMCs), alternating with elastin sheets and collagen fibers. The 
SMCs are responsible for the regulation of vessel size and elastin sheets are responsible 
for the vessel’s high compliance; 
(3) Adventitia, the outer layer, consists of collagen fibers disposed in a circumferential 
orientation that anchor the vessel to its surroundings. Fibroblasts may also be present 
[11]. 
A representation of the blood vessel structure is shown in Fig 1. 
 
Fig 1: Blood vessel structure 
28 
 
The complex structure of blood vessels is not easy to mimic. A number of solutions 
have been proposed for blood vessels repair from natural and synthetic polymers to the 
TE approaches, although none has shown to be entirely satisfactory especially when low 
diameter vessels are needed. 
 
2.2. Polymers in Vascular Tissue Engineering 
Tissue engineering (TE) aims to develop alternative materials able to restore, maintain 
or improve patient’s native tissue in order to reestablish its physiological function. Often it 
involves the use of synthetic or natural materials, denominated scaffolds, to provide a 
surface for cell growth and formation of a new tissue while degradation of the scaffold 
takes place [12]. 
Therefore, the traditional approach of te implies three contributions: 
(1) From cells that synthesize the new tissue; 
(2) From scaffolds that provide physical support to cells, and promote cell adhesion, 
migration, proliferation and differentiation; 
(3) From biomimetic in vitro culture environments, which are designed to replicate in 
vivo conditions by using biological inspired requirements, aiming at inducing cell 
differentiation, and promoting extracellular matrix (ECM) formation and maturation [4], 
[13]. 
In the classical TE strategy, the scaffold should serve as a limited time device: being 
foreign to the natural environment, it should disappear once that function has been 
fulfilled, leaving behind a viable purely biological system. Therefore, the majority of the 
materials used in tissue engineering are biodegradable. In the design of biodegradable 
biomaterials, many important properties must be considered. These materials must 
(1) not evoke a sustained inflammatory response; 
(2) possess a degradation time matching their function; 
(3) have appropriate mechanical properties for their intended use; 
(4) produce non-toxic degradation products that can be readily reabsorbed or 
excreted; 
(5) Include appropriate permeability and processability for specific applications. 
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The tissues of the human body are composed of two main constituents: cells, 
responsible for regulating body process and performing maintenance and wound healing, 
and ECM, the major structural component of the body. The ECM makes up a large majority 
of tissue volume, it consisting primarily of fibers with diameters between 50 and 500 nm 
[14]. The main goal of a scaffold is thus to mimic the advantageous characteristics of the 
ECM. The scaffold should be biocompatible, biodegradable and should meet the 
mechanical requirements suitable for its applications. 
 
The architecture of scaffolds used for TE is of critical importance. Scaffolds should 
have an interconnected pore structure and high porosity to ensure cellular penetration and 
adequate diffusion of nutrients to cells within the construct and to the ECM formed by 
these cells. One of the major concerns is core degradation due to the lack of 
vascularization and waste removal from the scaffold. The pores need to be large enough 
to allow cells to migrate into the structure, where they eventually become bound to the 
ligands within the scaffold, but small enough to establish a sufficiently high specific 
surface area. A porous structure will allow the diffusion of waste products out of the 
scaffold, allowing products of scaffold degradation to safely exit the body [15]. 
 
The vascular environment is subjected to cyclic pressure imposed by the heart, which 
influences the behavior of tissue cells. Blood vessels must be distensible for easy 
adaptation to blood in circulation, but they must also be stable to inflations over a range of 
pressure, presenting a non-linear elastic behavior. An ideal tissue engineered vascular 
graft should possess vasoreactivity and biomemechanics similar to native vasculature 
[13]. The mechanical properties of the selected materials are thus key elements in the 
design of vascular TE. The implantation of grafts or prostheses will cause mechanical 
restrictions during the cardiac cycle [15]. 
 
Naturally occurring polymers, and synthetic biodegradable polymers are the main 
types of polymers used in vascular TE. Natural materials owing to its bioactive properties 
have better interactions with the cells which allow them to enhance the cell’s performance 
in biological systems. However their poor mechanical properties, high composition 
variability and fast degradation constitutes its most serious drawback. Examples of natural 
polymers used in vascular TE are shown in Fig 2 [3]. 
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Synthetic biodegradable polymers are highly useful in TE, since their properties can 
be tailored for specific applications [12]. Synthetic biodegradable polymers can be 
produced under controlled conditions, exhibiting predictable and reproducible mechanical 
and physical properties, such as tensile strength, elastic modulus and degradation rate 
[12]. 
Examples of synthetic biodegradable polymers include poly(Ɛ-caprolactone), poly(L- 
lactide) and poly(glycolide). 
Biodegradable polymers (BP) degrade via hydrolytic cleavage at the ester bond, 
producing fragments of low molecular weight. BP degradation is detected through the loss 
of mechanical properties, followed by the decrease of BP mass/volume. The rate of 
degradation of the polymer depends on its initial molecular weight and crystallinity, and on 
the exposed surface area [1]. 
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Fig 2: Examples of natural polymers used in Tissue Engineering 
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2.3. Non degradable polymers for blood vessels grafts 
Any artificial vessel substitute should ideally fulfill the following requirements: 
(1) To be biocompatible and biostable: non-inflammatory, nontoxic, non-carcinogenic, 
and non-immunogenic; 
(2) To be thromboresistant: to be impervious to blood, but to have adequate porosity; 
(3) To remodel well, including easy regrowth of endothelium, which is a secretory 
tissue as well as a selective permeability barrier; 
(4) To resist to infection; 
(5) To be compliant (elastic): it must have appropriate mechanical properties; 
(6) To be vasoactive: to possess appropriate vasoactive physiological properties 
including the ability to constrict or relax in response to neural or chemical stimuli; 
(7) To offer a long-term tensile strength; 
(8) To be of easy handling; 
(9) To have suture holding strength, being able to allow sutures; 
(10) To be easily available in appropriate specifications; 
(11) To be easy to manufacture [3] 
 
 
Natural polymers have been investigated for clinical applications as blood vessel 
substitutes due to their high biocompatibility but, their poor mechanical properties, high 
composition variability and fast degradation are as major drawbacks for vascular 
applications. Synthetic polymers were thus exploited. Among them, the polyester 
poly(ethylene terephthalate) (PET) and the fluoropolymer poly(tetrafluorethylene) (PTFE) 
have been highly used for the development of vascular grafts. PET (Dracon) and PTFE 
(Gore-Tex) were the first to obtain a FDA approval. Dacron, a thermoplastic polymer, 
consist of tubular structures of poly(ethylene terephthalate) and was first introduced in 
1957. It has high crystallinity, high elastic modulus and tensile strength. Gore-Tex, which 
is expanded poly(tetrafluorethylene) (ePTFE), also presents high crystallinity and high 
stiffness, both lower than Dracon. Dracon and Gore-Tex show good results for application 
in grafts with internal diameter greater than 6 mm (between 7-9 mm). 
However, both grafts fail in small diameter (<6mm) applications, mainly due to their 
poor blood patency rate, high stiffness and compliance mismatch [6], [7], [9], [13]. 
Altogether these factors result in an unavoidable thrombogenicity and an 
unsatisfactory prostheses performance for diameters smaller than 6 mm. 
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2.4 The chemistry of polyurethanes 
Polyurethanes have  been  used  as  a  biomaterial  for  many  years,  due  to their 
mechanical properties, biocompatibility, and flexibility [16]. Traditional applications of PU 
involve catheter, transdermal patches, transient cardiovascular devices, among others 
[17]. PU vascular grafts can withstand the action of stress and load and undergo elastic 
recovery with little to no hysteresis. The high variability of PUs chemistry and their 
properties, allow the design of biocompatible material with controlled physical, chemical, 
mechanical and biodegradation properties, through the selection of the appropriate 
monomers and by manipulating hard and soft segment contents[18]. These polymers are 
characterized by the presence in their chain of one or more urethane linkages. The 
urethane linkage established by the reaction between the two basic components of 
polyurethane, a polyol and an isocyanate. This type of link was first discovered in 1849 
when Wurtz and Hoffman studied the reaction between an isocyanate and a compound 
with alcohol functional groups. Figure 3 describes the reaction between an isocyanate and 
a polyol. 
As represented in Fig 3, polyurethane (PU) is formed from two precursor compounds, 
the polyol and diisocyanate (4,4′-MDI) which will be addressed in the next sub- sections A 
third compound might be used as a chain extender, usually a diol or amine (Figure 3) [19]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3: Schematics of polyurethane synthesis 
4,4′-Methylenebis(phenyl isocyanate) 
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Polyol 
Conventional polyols are either a polyether or a polyester (-R-O-R'- or -R-COO-R'- 
respectively), with a hydroxyl termination. When aliphatic polyols and low intermolecular 
interactions are concerned, polyols are flexible, and consequently are referred to as 
flexible portion of the PU. Polyethers are more hydrolytically stable than polyesters, and 
are usually used when high flexibility and extensibility are needed [20]. 
Table 1 shows a list of the most commonly used polyether and polyesters. 
 
Table 1 - Examples of most commonly used polyether and polyesters. 
                            Polyether Polyester 
Poly(ethylene oxide) (PEO) 
 
 
Poly(ε-caprolactone) (PCL) diol 
 
 
 
 
Poly(propylene oxide) (PPO) 
 
 
Poly(d,l-lactide) (PDLLA) diol 
 
 
 
 
 
Poly(tetramethylene oxide) 
(PTMO) 
 
 
Poly(glycolide) (PGA) diol 
 
 
 
Poly(hexamethylene oxide) 
(PHMO) 
 
 
Poly(ethylene adipate) diol 
 
 
 
 
 
 
 
34 
Isocyanate 
The two main classes of isocyanates used to generate biomedical polyurethanes are 
aromatic and aliphatic. The most important isocyanate used in the synthesis of the 
polyurethane is the diisocyanate, which contains two isocyanate groups per molecule. 
An example is shown in Fig 4 where we can see the representation of Lysine methyl 
ester diisocyanate (LDI) with two isocyanate groups highlighted. 
 
 
These two functional groups have the function of linking, through a chemical reaction, 
the two other molecules required for the synthesis of a PU (two polyols, or a polyol and a 
chain extender) forming a linear chain. When the functionality of the isocyanate is greater 
than two, a linkage between molecules can be established, leading to the formation of a 
crosslinked network. Due to the ring shaped structure of the diisocyanates, and due to 
their strong intermolecular interactions, the resulting chain in this case is referred to as the 
rigid chain of the PU. Amongst the most used diisocyante structures one can cite: 1,4-
Diisocyanatobutane (BDI); 1,6- Diisocyanatohexane (HDI); Lysine methyl ester 
diisocyanate (LDI) and Methylene diphenyl diisocyanate (MDI) [18]. 
 
 
 
 
 
Fig 4: Lysine methyl ester diisocyanate (LDI) and Methylene diphenyl diisocyanate (MDI) 
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Chain Extenders 
Chain extenders are low molecular weight diols or diamines that react with 
diisocyanates to build polyurethane molecular weight and increase the block length of the 
hard segment. Chain extenders made from diols such as ethylene glycol, butane diol, and 
propylene glycol result in a urethane linkage [21], [22]. 
The use of diamine chain extenders results in a urea linkage. They are associated to 
increased modulus and tensile strength and to decreased elongation of PU, as compared 
to their diol counterparts [23]. 
 
 
2.5 Polyurethanes for vascular repair 
Polyurethanes (PU) appeared as alternative graft materials due to their 
biocompatibility and mechanical properties, especially low temperature flexibility, abrasion 
resistance, controllable stiffness and fatigue resistance, which offer a very good match to 
the native vascular tissue [24]. Additionally PUs are not expensive and are easily 
processed. 
These same properties have allowed the application of PU in the biomedical industry 
since the 1960s [25]. PU are currently used in the production of heart valves, blood 
storage bags, dialysis membranes, prostheses, bone adhesives, sutures and drug 
controlled release systems [26]. 
 
Different manufacturing techniques can be used to produce the PU structures 
depending on the envisaged morphology. Recently electrospinning appears as a very a 
versatile technique allowing the production of nanofiber membranes with a microstructure 
that closely resembles the ECM. 
 
Several studies are reported on the production of PU membranes for different 
applications. A review of some of those studies is presented bellow and details on the 
electrospinning technique used in the meshes fabrication are presented in  
Eectrospinning was used to pattern the luminal surface of small-diameter PU grafts, 
prepared from aromatic commercial PU (Tecothane) with microfibres and microgrooves 
was developed [27]. The biocompatibility of the designed grafts was measured by seeding 
its patterned luminal surface with endothelial cells and then following their growth and 
orientation on this surface. Uttayarat et all [27] concluded that the micropatterned vascular 
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grafts were able of promoting the formation of aligned and cytokine-responsive endothelial 
monolayers. 
A PU surface modification was proposed by Blit et al.[28], who used elastin cross- 
linked peptide (ECP) to modify PU surface. The PU matrix was obtained from 
poly(hexamethylene carbonate) diol (Mw= 860), 1,6-hexamethylene diisocyanate (HDI) 
and 1,4-butanediol (BDO) as chain extender. The surface of the obtained electrospun PU 
scaffolds, with fibrous structure, was modified by recombinant elastin-like polypeptide-4 
(ELP4). The prepared scaffold was used as a support for vascular smooth muscle cells 
(SMCs) adhesion and then examined. Scaffold surface modification by ELP4 caused the 
enhancement of the cells adhesion and proliferation thus improving PU biocompatibility. 
The effect of solvent ratio (DMF/ THF) (Dimethylformamide/Tetrahydrofuran) and 
rotational speed on the mechanical properties of electrospun grafts obtained from 
poly(ether urethane) (SPEU) was studied by Matsuda et al. [29]. It was observed that an 
increase of the DMF/THF ratio led to fiber fusion and to a decrease in fiber diameter, 
leading to lower compliance values [29]. An increase of the rotational speed led to stiffer, 
less compliant tubes. Another study confirmed that an increase in the DMF/THF ratio 
significantly increased fiber bonding and elastic modulus. 
Carbothane® PC3575A (Carbothane, Lubrizol), a poly(carbonate urethane) (SPCU) 
containing MDI  and HMDI, respectively was tested by Nezarati et al [30] to evaluate  its 
mechanical behavior on a vascular graft application. Due to its content of aliphatic hard 
segments, Carbothane® had a lower initial Young’s modulus, and an increased 
compliance, and was used for the fabrication of an electrospun vascular graft. Fiber fusion 
generated by heat treatment led to vascular grafts with both compliance and burst 
pressure exceeding saphenous vein’s autografts. 
Eectrospun grafts obtained from poly(ether urethane) (SPEUs) were prepared by 
Cozzens et al, [31] using hydroxypropyl telechelic polyisobutylene (PIB) and 
polytetramethylene oxide (PTMO) (80:20) as soft segments, and MDI and Butanediol 
(BDO), with variation of the ratio of the hard segments. The obtained SPEUs were 
electrospun as flat meshes and displayed higher mechanical properties than native 
vessels, suggesting that they are promising materials for the production of biostable 
vascular grafts. An increase of the Young’s modulus and tensile strength was observed. 
Han et al. [32] synthesized a SPEsUU from PCL, l-lysine ethyl ester diisocyanate 
(LDI), and l-lysine ethyl ester (LEE) as chain extender. The mechanical properties of the 
electrospun tubular scaffolds were dependent of the solution concentrations, as a higher 
concentration leads to a higher diameter, and therefore enhance mechanical properties. 
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The values of suture-retention strength were higher than those of native blood vessels, 
whereas the burst pressure strength was slightly lower. 
Another important aspect of the development of vascular tissue engineering is 
bioresorbability/biodegradability of PUs. 
Using polycaprolactone diol (PCL-diol) (Mw = 1250), 2,6-diisocyanate methylcaproate 
(LDI) and L-phenylalanine-based diester chain extender  for the PU synthesis, Rockwood 
rt al tried to increase the biodegradability of the electrspun isotropic PUs scaffold (ES-PU). 
As it is commonly known PU formed from polyester polyols is more susceptible for 
degradation than polyether polyols. The authors concluded that the physical organization 
of microfibres in ES-PU scaffolds impacts both multi-cellular architecture and cardiac cell 
phenotype in vitro. Isotropic and aligned microfibrous templates were capable to support 
primary cardiac cell cultures in a serum free medium. 
 
Polyurethanes (PUs) of increased biodegradability were prepared by Han et al [33] 
through synthesis of poly(ε- caprolactone)diol (PCL)  with two different molecular masses: 
Mw = 2000 and Mw = 1250, which reacted with L-lysine ethyl ester diisocyanate (LDI). 
The PU membrane, obtained via electrospinning, displayed enhanced tensile strength, 
burst pressure strength and suture retention strength. In general, the physico-mechanical 
parameters were improved with increasing solution concentration of PU. The cytotoxicity 
and cell adhesion were measured with the use of L-929 fibroblast cells and HUVECs. The 
results revealed that the obtained scaffolds provided cells proliferation and adhesion, 
proving that material may serve as blood vessel graft. Using naturally occurring peptides, 
such as elastin, which participate in ECM formation and tissue remodeling, the probability 
of healthy soft tissue reconstruction is increased. 
 
To study the effect of porosity on cellular growth and migration Bergmeister et al.[34]. 
prepared Pellethane® small-diameter vascular grafts. It was observed that grafts with 
higher porosity exhibited higher cell attachment after implantation; while the values of 
compliance and tensile strength remained higher compared to native blood vessels for 
grafts before and after 6 months of implantation in rats. Pellethane® usage has been 
restricted to short term periods due to its biodegradability in long-term applications. 
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To avoid clot formation due to thrombogenicity it is also important to focus on the PU 
surface. The main approach employed is by modification of PU’s membranes surface, 
usually by incorporation of compounds such as heparin or nitric oxide, both known for 
their aintithrombogenic properties [35]. 
 
With the growing public health awareness associated with the pathogenic effects 
caused by microorganisms, there is an increasing need for antibacterial materials in many 
application areas like medical devices and health care in general. Although PU 
membranes exhibit quite adequate properties for vascular grafts applications, they lack 
antibacterial activity. Specific additives or fillers may be blended with the PU matrix in 
order to induce this biocide ability. 
 
Zinc oxide nanoparticles are of great interest in the biomedical field due to its 
antibacterial activity. The possibility of filling PU membranes with ZnO nanoparticles 
appeared as quite adequate. Despite all reported investigations on the interactions 
between cells and nanoscale surfaces of biomaterials, to our knowledge the antibacterial 
behaviour of electrospun ZnO-added PU membranes, has not been studied so far. 
 
 
 
2.6 Zinc Oxide 
ZnO may be described as a functional, promising and versatile inorganic material with 
a broad range of applications. Due to the Zn and O position on the periodic table (groups 
II and XI respectively), ZnO holds unique optical, chemical, semiconducting and 
piezoelectric properties which allow ZnO to have a wide range of applications across 
many different fields such as sensors, transducers and catalysts [36]. 
 
Crystal structure of ZnO and particles morphology 
Zinc oxide crystals possess a wurtzite structure at ambient conditions. As seen in Fig 
5Erro! A origem da referência não foi encontrada. The structure is composed of two 
interpenetrating hexagonal closed packed (HCP) sublattices, each of them consisting of 
one type of atom (Zn or O) displaced along the c-axis. Each Zn atom is surrounded by 
four oxygen atoms and vice-versa. The ZnO structure can be explained as a number of 
alternating planes stacked layer by layer along the c-axis direction and composed of 
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tetrahedrally coordinated Zn2+ and O2− with lattice parameters a = 0.3296 and c = 0.52065 
nm. The structure is thermodynamically stable in an ambient environment [37]. 
 
 
Fig 5: Zinc Oxide structure 
 
ZnO particles can be produced with different sizes and shapes. The nanoscale size 
usually confers large surface area to nanoparticles, compared to macrosized particles. 
Nanoparticles show size related properties significantly different from those of bulk 
materials. Given the versatility of their properties the small size, nanoparticles applications 
are very broad and  can range from biosensors to nanomedicine [38]. 
Due to the great potential of ZnO in many fields, various synthetic methods have been 
used to grow a variety of ZnO nanostructures, such as nanoparticles, nanowires, 
nanorods, nanotubes and other complex morphologies. Depending on the final 
application, different methods are available to produce different morphologies. and 
properties as resumed in Table 2 [39]. 
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Table 2 - Different processes to synthesize ZnO nanoparticles 
 
 
  
In the present work, ZnO will be obtained through chemical precipitation at room 
temperature, as will be later detailed in Chapter 3. This technique presents several 
advantages, mainly its low cost, as it can be performed at room temperature and does not 
require expensive reagents or complex equipment [40]. 
 
 Antibacterial Properties of ZnO Nanoparticles 
 
Antibacterial agents are of great relevance to a number of industrial sectors, including 
environmental, food, synthetic textiles, medical care among many others. Antibacterial 
agents can be classified as, organic and inorganic [41]. Organic agents, possess a 
drawback as they are less stable at higher temperatures when compared to inorganic 
ones. Inorganic agents are mainly composed of metal and metal oxides, such as Ag, TiO2, 
ZnO, MgO and CaO. Some of these oxides are part of essential minerals for human 
Author Techniques ZnO morphology 
Jalal et al. Microwave decomposition Sphere 
Ramani et al, Simple wet chemical route Nano and micro-flowers, rice 
flakes and rings 
Kumar et al Simple precipitation 
method 
Nano-flakes 
Stankovic et al Hydrothermal synthesis Hexagonal prismatic rods 
Talebian et al. Solvothermal method Nano-flowers, nano-spheres 
Ma et al. Microwave hydrothermal 
method 
Mulberry-like 
Hafez et al. Hydrothermal technique Nanorods 
Chen et al 
 
 
Chemical precipitation Nano-flakes 
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health (MgO and CaO), while others have been used extensively in the formulations of 
personal care products [42]. 
Metal oxides nanoparticles represent a new class of important materials with a recent 
increased use in health related applications. ZnO powder has been used as an active 
ingredient for dermatological applications in creams and lotions due to its antibacterial 
properties [43]. On a nanoscale ZnO nanoparticles can interact with bacterial surface and 
bacterial core, resulting in toxic interactions. However, ZnO nanoparticles have proven to 
be non-toxic for human cells. 
Several studies have already been performed, proving the antibacterial properties of 
ZnO nanoparticles, while establishing a relation between the size of the particles and their 
antibacterial properties. 
Different methods have been adopted for the assessment and investigation of the in 
vitro antibacterial activity of ZnO alone or combined with other components. These 
methods include disk diffusion, broth dilution, agar dilution, and the microtiter plate-based 
method. 
 
Li et al studied the effect of ZnO nanoparticles on the mechanical and antibacterial 
properties of PU thin films, prepared by solvent casting and evaporation technique [36]. 
ZnO nanoparticles were obtained through coprecipitation using Zn(O2CCH3)2·2H2O and 
(NH4)2CO3 as precursor reagents and the obtained crystals, with hexagonal structure 
exhibited an average size of 27 nm. The Young modulus of the ZnO-PU composite film, 
as compared to pure PU films, appeared to increase with the ZnO concentrations up until 
2 %, a further increase of concentration resulted in a decrease of the tensile strength as 
seen in Table 3. 
 
 
Table 3 - Mechanical properties, (Young's modulus and tensile strength) of composite ZnO-PU films 
obtained by solvent casting. 
 
ZnO 
(wt%) 
 
Young's modulus 
(MPa) 
 
Tensile strength 
(MPa) 
0.0 517,42 8,58 
1.0 660,34 16,74 
2.0 710,48 17,83 
3.0 557,7 10,42 
4.0 512,76 7,24 
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The same authors reported the results of antibacterial tests with the ZnO-PU 
composites performed according to the agar dilution method against E. coli and B. subtilis 
The results indicated that the composite films possess excellent antibacterial property and 
the increasing antibacterial efficiency correlates with the increase of ZnO content. A higher 
efficiency against E. coli as compared to B. subtilis was observed [43].The anti-bacterial 
properties of several metal oxide nanoparticles were also studied by Jones et al [44]. ZnO 
nanoparticles (50 - 70nm), obtained from Sigma-Aldrich, were suspended in sterile 
double-distilled water. Turbidity as a qualitative measure was used to examine the anti-
bacterial activity, at 600nm. The results showed that for the tested concentration (1nM) 
ZnO   nanoparticles   produced   a   95%   growth   reduction   of Staphylococcus aureus, 
while ZnO ultrafine powder (average size >1µm) only produced 50% of growth reduction, 
proving that the antibacterial activity has an important dependence on the particle size. 
 
Together with particle size, concentration of particles in the antibacterial medium also 
revealed to have major importance. Commercial ZnO particles with sizes in the ranges 24-
71 nm and from 90 - 200nm have been tested by Zhang et al against E. coli growing in a 
Luria-Bertani (LB) medium. Antibacterial tests were performed by measuring the growth 
curve of E. coli incubated in the LB broth medium in the presence of the nanofluids 
containing different concentrations of ZnO nanoparticles. The results showed that the 
antibacterial activity increased with the increasing particle concentration and the 
decreasing particle size, being the particle concentration more significant than the particle 
size particle size under the conditions of this work [42]. 
 
 
 
As shown in the literature ZnO shows antibacterial behavior against either Gram 
positive or Gram negative bacteria. It is accepted that this behavior results from the 
binding of ZnO particles to the cell membrane of the bacteria, damaging it, as a result of 
the production of reactive oxygen species (ROS) which plays a very important role in the 
disorganization and disruption of this membrane [45]. 
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The term reactive oxygen species (ROS) is used to refer free radicals derived from 
molecular oxygen. They can be the byproduct of several biological processes, and can be 
harmful for the cell. In the case of zinc oxide, the reactive species are hydroxyl anion (OH-), 
superoxide anion (O2-) and hydrogen peroxide (H2O2) which can be formed by several 
routes, namely the photocatalysis on the surface of a particle (Fig 6). Under action of UV 
or visible radiation, whose energy is higher than 3.3 eV, electrons from the ZnO valence 
band move to its conduction band. Thus they form holes (h+) in the valence band and free 
electrons (eˉ) in the conduction band (equation a, Fig 6). The h+ holes react with the water 
present in the medium producing H+ and -OH (equation b, Fig 6), the electrons react with 
the oxygen, also present in the medium, giving rise to the superoxide anion · O2ˉ 
(equation c, Fig 6), which in turn reacts with H+ to give the hydroperoxyl · HO2 radical 
(equation d, Fig 6). This radical then reacts with another free electron producing the 
hydrogen peroxide anion HO2ˉ (equation e,Fig 6), which will react with the H+ ion leading to 
the formation of the hydrogen peroxide molecule H2O2 (equation f, Fig 6) [46]. 
 
 
Fig 6: Mechanism of action for different types of ROS produced by ZnO 
 
 
The toxicity of ROS is attributed to their high reactivity and oxidation capacity, which 
results in the destruction of cellular components such as lipids, DNA and proteins [47]. 
Literature reports that the action of ROS can lead to loss of cell membrane integrity, 
resulting in dysfunctionalities in the permeability barrier, which will result in the death of 
the cell. The ROS mechanism begins with the release of oxygen species from the surface 
of the particles, which react with the cell membrane, causing its rupture through lipid 
peroxidation, exposing the cellular content. ROS can then penetrate into the cell and react 
with nucleic acids and proteins [48]. 
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ROS can be quantified for example by the amount of glutathione in its oxidized form 
(GSSH). Glutathione (C10H17N3O6S) is a non-enzymatic, water-soluble antioxidant, and is 
recognized as the most important non-protein thiol in living systems. It is a linear 
tripeptide, consisting of three amino acids: glutamic acid, cysteine and glycine. It exists in 
most cells at concentrations ranging from 1 to 8 mM and may be in reduced (GSH) or 
oxidized form (GSSH). The importance of this pair is such that the GSH / GSSH ratio is 
normally used to estimate the oxidative state of biological systems [48]. 
 
 
 
2.6 Electrospinning 
Currently, nanofibers have attracted tremendous attention due to their enormous 
potential for a wide range of applications. The most growing applications include filtration, 
tissue engineering, biomaterials, nanocomposites, and drug delivery[49]. Among the 
several approaches for the preparation of fibers, electrospinning has emerged as a 
straightforward and cost-effective technique for the convenient fabrication of nanosized to 
microsized fibers from a variety of materials [6]. 
The electrospinning phenomenon was first observed by Rayleigh in 1897, and was 
patented in 1934 by Formhals [50]. Since then several upgrades have been made to the 
equipment design and applications, such as the use of polymer for biomedical 
applications. Electrospinning relays on the electrostatic force to create fine fibers from a 
polymer solution. The electrospinning equipment is simple and comprises a syringe pump, 
a syringe with a metal needle loaded and with a polymer, a conductive collector and a 
high voltage supply (Fig 7) [51]. 
 
 
Fig 7: Schematics of the Electrospinning equipment 
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The high voltage will charge the polymer solution leading to the starching of the liquid, 
forming the Taylor cone. The induced electrostatic repulsion will reach a critical value that 
will overcome the surface tension of the liquid, and the polymer solution and then travels 
toward the charged collector as the solvent evaporates. The dried polymer fibers deposit 
onto the collector as randomly oriented or aligned pattern of fibers, depending on the type    
of the collector. 
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Author Solvent Concentration Voltage Flow Rate Objectives 
Amna et al. DMF, THF NA 20 kV NA Vascular grafts 
Blit et al HFIP 16 wt% 12kV 0,5 ml/ h Increase PU degradation 
Caracciolo et 
al 
HFIP 5-30 wt% 10-20 kV 0,5- 3 ml/ h Soft tissue Eng. 
Chen et al HFIP 6 wt% 20kV 0,8- 1,2ml/ h Vascular grafts 
Courtney et al HFIP 5 wt% 15 kV 1,0 ml/ h Scaffold production 
Gluck et al HFIP 5 w/v % 28kV 0,07 ml/ h Scaffold production 
Grasl et al HFIP 5 wt% 20kV NA Vascular grafts 
Han et al HFIP 5 w/v% 15kV 0,8 ml/ h Increase PU biocompatability 
Huang et al HFIP 6 w/v% 15 kV 1 ml/ h  Vascular grafts 
Matsuda et al THF; DMF 15 wt% 30 kV NA Small dimention grafts 
Milleret et al HFP/ 
Chloroform 
15- 25 wt% 15 kV;  NA Vascular grafts 
Rockwood et 
al 
DCM 18 w/v% 1-15 kV 1,5 ml/ h Limit peptid expression 
Soletti et al HFIP 8 w/w% 10 kV NA Vascular appilcations 
Uttayarat et al HFIP 5 w/v% 12 kV 0,8 ml/ h Vascular grafts 
Wang et al THF; DMF 10 w/v% 18 kV NA Increase hemocompatability 
Williamson et 
al 
DMF 20 w/w% 12- 15 kV NA Vascular tissue scaffolds 
Youan et al DMF, THF 10 w/v% 16kV 0,6 ml/ h Vascular grafts 
Table 4- Electrospinning parameters gathered from previous studies 
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Electrospinning operative conditions 
The efficient operation of the electrospinning equipment requires the observation of 
some parameters and characteristics of the solutions, which are detailed below. 
 
Voltage 
It is known that the flow of current from a high-voltage power supply applied into a 
solution via a metallic needle will cause a spherical droplet to deform into a Taylor cone 
and form ultrafine nanofibres at a critical voltage, determined by the type of polymer. 
Although drops may form at relatively low voltage, voltage increase will produce fibers 
with reduce diameter, due to the stretching of the polymer solution which correlates with 
the charge repulsion within the polymer jet. However, when the voltage is too high, the 
process becomes unstable. Thus, an optimum voltage is required for a stable 
electrospinning process [52]. 
 
Flow Rate 
The flow rate of the polymer solution is very important in the electrospinning process; 
it is regulated by the syringe pump. Usually, increasing the flow rate will originate an 
increase in fiber diameter and a slow flow rate may induce a temporary break in the 
electrospinning process. Polymer drops may form when the flow rate is too high as the 
fiber production rate cannot keep up with the flow rate. The ideal situation is that a stable 
Taylor cone forms during electrospinning, and the fiber formation rate is equal to the 
infusion rate, resulting in a stable process [51]. 
 
Effect of needle to collector distance 
The distance between the needle tip and the collector is usually a neglected 
parameter. The distance is related to the solvent evaporation and the electrostatic force. 
Increasing distance will lead to a better evaporation of the solvent giving thinner fibers. 
Shorter distances will originate thicker fibers as the solvent may not evaporate completely, 
it may also lead to increased fiber fusion [51]. 
 
Tip Diameter 
The tip diameter is closely related to the formation of a stable Taylor cone, but it does 
not affect the fiber diameter [50]. 
48 
 
 
 
Effect of polymer concentration 
Altering the polymer concentration is an effective way to optimize the fiber diameter. 
The polymer concentration is associated to the viscosity of the solution an increase of 
polymer concentration will lead to an increase in the viscosity of the solution and will 
originate a large fiber diameter; on the other hand, lower concentration will lead to the 
formation of polymer beads as continuous polymer fiber cannot be achieved. Thus, an 
appropriate polymer concentration is very important to the process of electrospinning [50]. 
 
Solvent 
The main requirement for an electrospinning solvent is high volatility, as the solvent 
should evaporate quickly. Another important parameter is its electrical conductivity: a 
highly conductive solvent will produce thinner fiber diameters, and a polymer solution with 
low conductivity tends to form drops during the process [50]. 
 
Polymer properties 
The overall structure of the polymer will affect the fiber formation. Polymers must be 
soluble in the organic solvent. Hence, crosslincked polymers and some linear polymers 
with high crystallinity cannot be electrospun. The molecular weight affects the rheological 
and electrical properties of the polymer solution such as viscosity, surface tension and 
conductivity. Generally, the fiber diameter increases with increasing polymer molecular 
weight. Low molecular weight will result in a small number of polymer chain 
entanglements in the solution, resulting in increased difficulty for the polymer chains to 
form fibers [50]. 
For the case of PU fibrous membranes produced by electrospinning, a resume of the 
experimental conditions used by different authors is presented in Table 4. 
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CHAPTER III – MATERIALS AND METHODS 
 
In the present chapter, the procedures and techniques used in this study will be 
described. The first sections refer the used materials and reagents, as well as the 
techniques employed in the synthesis of zinc oxide nanostructured particles (nZnO) and in 
the preparation of the composite membranes of PU and zinc oxide (PU/ZnO) composites. 
Briefly, nZnO were synthesized by a chemical precipitation method, using different 
concentrations of reagents and different addition rates of reagents, in order to produce a 
wide range of particles, from which the one with larger specific surface area was chosen.  
The experimental protocol for carrying out antibacterial activity tests is also described 
below. A brief report of all the characterization techniques used throughout this work is 
presented as well. 
 
3.1. Materials and Reagents 
In the following table (Table 5) are presented the materials and reagents used in the 
synthesis of ZnO nanoparticles and in the production of composite membranes, and 
respective purity and commercial supplier. 
 
Table 5 - Materials and reagents used in the synthesis of ZnO nanoparticles and in the production of 
PU/ZnO composites. 
Reagents Chemical Formula Supplier Purity 
Citric Acid 
Monohydrated 
C6H8O7.H2O Sigma-Aldrich >99.5 
Zinc Chloride ZnCl2 Aldrich ------- 
Absolute Ethanol C2H5OH Carlo Erba >98 
Sodium Hydroxide NaOH Sigma-Aldrich >98.5 
Polyurethane PU Sigma-Aldrich ------- 
Tetrahydrofuran C4H8O Carlo Erba ------- 
Dimethylformamide C3H7NO Carlo Erba ------- 
 
 
 
 
 
 
 
 
52 
3.2. Synthesis of Zinc Oxide Nanoparticles 
Zinc oxide nanoparticles were synthesized using a chemical precipitation method at 
room temperature, as described in the literature and optimized by previous works 
developed at the Department of Materials and Ceramic Engineering of the University of 
Aveiro [53]. 
The method is based on the addition of a basic solution (sodium hydroxide) to an 
acidic solution of zinc ions (Zn2+) (i.e zinc chloride acidified with citric acid). The resulting 
precipitate is a white powder composed of zinc oxide nanostructured particles (nZnO). 
In the following scheme (Fig 8) is represented the overall process used in the 
synthesis of nZnO.  
 
 
Fig 8 - Flowchart for the production of ZnO nanoparticles via chemical precipitation 
. 
 
The additions of the basic solution to the acidic solution of Zn2+ were made using a 
burette. The schematic of the used apparatus is presented in Fig 9. 
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Fig 9 - Schematics of the apparatus used in the production of ZnO nanoparticles: the hydroxide solution 
contained in the burette was dropped over the acidic solution of the cation inside the bottom Erlenmeyer 
 
In this study, several types of ZnO powders were produced Table 6. The only 
difference in the synthesis method was the ratio between Citric Acid (Cit) and Zinc 
Chloride, and the flow rate of the added solution to the bottom Erlenmeyer. 
 
Table 6 - Different conditions used for the production of ZnO nanoparticles 
 
nZnO 
label 
Addition 
rate 
(mL/min) 
(Cit:Zn2+) 
molar 
ratio 
nZno 1 18 2.7:1 
nZno 2 13 3:1 
nZnO 3 11 3:1 
nZnO 4 10 3:1 
nZnO 5 16 3:1 
 
Three solutions (solution 1, 2 and 3) were prepared for the synthesis of the ZnO 
nanoparticles: two basic solutions and an acid solution.  
Solution 1 consists of sodium hydroxide (NaOH) (10 M concentration) dissolved in 
distilled water (H2O), under magnetic stirring (30 rpm) for 5 minutes. 
The pH value of this solution was approximately 14.  
The preparation of the acidic Zn2+ solution (Solution 2) was made mixing 
Monohydrated Citric Acid and Zinc Chloride (ZnCl2) in distilled water, under magnetic 
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stirring. The pH of this solution was approximately 1. The Zn2+ ion concentration of this 
solution was 1.16 mol/ L and 1.07 mol/ L for nZnO-1 and nZnO-2, respectively. 
Solution 3 was prepared by mixing the ethanol and the sodium hydroxide solution in a 
ration of 1,3:1 (hydroxide solution : ethanol). 
The quantities of reagents used in the preparation of solutions 1 and 2 for the 
synthesis of the two types of zinc oxide powders, ZnO-1 and ZnO-2, are summarized in 
Table 7. 
 
 
 
Table 7 - Quantity of reagents used in the preparation of the solutions for the nanoparticles synthesis. 
 Solution 1 Solution 2 
 NaOH (mmol/ml) Citric Acid (mmol/ml) ZnCL2 (mmol/ml) 
nZnO-1 10 2.86 1.16 
nZnO-2 10 3.24 1.06 
 
 
The solution 2 was placed in the Erlenmeyer under constant magnetic stirring. 
Solution 3 was then added through the burette, followed by the addition of the solution 
1. As a result of this process a suspension of nZnO is obtained, with a pH of 
approximately 13.   
The nZnO suspension then undergoes 10 cycles of centrifugation at 10000 rpm for 10 
minutes. The resulting sediment is washed with distilled water after each cycle. The 
washing cycle’s main goal is the elimination of sodium ions (Na+) for obtaining pure zinc 
oxide. 
Finally the precipitate was dried overnight in an oven at 60ºC.  
All the precipitated powders were observed by scanning electronic microscopy (SEM) 
on a SU-70 Hitachi equipment. Crystalline phase composition and crystallite size were 
evaluated by x-ray diffraction (XRD) analysis on a PANalytical X’PertPRO diffractometer 
in a 20º<2ϴ<80◦ range. 
Elemental phase composition was confirmed by the Energy Dispersive Spectroscopy 
(EDS) equipment coupled to the electronic microscope. Specific surface area, and pore 
size distribution were determined by gas (N2) adsorption based on Brunauer-Emmett-
Teller (BET) isotherm using a micromeritics datamaster equipment. The used 
degasification temperature was 100ºC for 16h. 
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3.3. Pu/ZnO Membrane production and characterization 
Several composite samples (0, 10, 25 and 50% mass of ZnO in regards to the mass 
of PU) were produced using the electrospinning technique (Fig 10). The different 
concentrations of nZnO were chosen to study the effects of nZnO concentration in both 
the mechanical and the anti-Bacterial properties of the composite membrane.  
 
 
 
Figure 10 shows the apparatus used for the electrospinning technique, were the 
polymer solution is place inside a syringe that is connected to a needle located at a fixed 
distance from the collector. The polymer solution is pumped through the needle tip and an 
applied electric field causes the evaporation of the solvent, resulting in the deposition of 
fibres in the collector.   
To produce the membranes, PU pellets were dissolved in dimethylformamide and 
tetrahydrofuran (1:1), until complete dissolution. The ZnO precipitated powder was then 
added to the polymer solution, under constant stirring. For this experiment, it was used the 
ZnO powder with the higher specific surface area (nZnO1) 
To produce the 10, 25, and 50% PU/ZnO composites, 1 g of PU was dissolved in a 10 
ml mixture of DMF and THF (1:1). Then, different quantities of ZnO powder were added to 
the solution, in order to attain the desired concentration, and were left under constant 
stirring overnight. The amounts of the several reagents necessary to the preparation of 
the different types of PU/ZnO composites are presented in Table 8. The final solutions 
Fig 10 - Electrospinning apparatus used 
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were electrospun using a flow rate of 0.5 mL/h, with the distance between the tip of the 
needle and the collector of 17cm, and with a voltage of 15kV.  
The 0% membrane (pure PU) was produced by adding 1 g of PU to 10 ml solution 
composed of DMF and THF (1:1), left under constant stirring overnight, and electrospun 
using the same conditions as previously mentioned. 
 
Table 8 - Quantities of the precursors used in the preparation of the various composites. 
ZnO 
amount on 
the 
PU/ZnO 
composites 
DMF (ml) THF (ml) PU (g) ZnO (g) 
0%  
5 
 
5 
 
1 
0.00 
10% 0.10 
25% 0.25 
50% 0.50 
 
Fig 12 summarizes the main steps followed in the preparation of the PU and PU/ZnO 
composite membranes. 
Keeping in mind the vascular application of the membranes to produce in the present 
work it was important that the average fiber diameter was identical to the ECM fibers 
diameter [4]. For that, several electrospinning conditions were tested. 
The electrospun solution was composed of 1g of PU dissolved in 10 mL of a mixture 
of DMF and THF (1:1). The tested conditions were as resumed in Table 9. 
 
Table 9: Tested parameters for the different set of conditions  
 
Conditions 
 
Voltage  
(kV) 
 
Flow rate  
(mL/h) 
Distance from 
collector 
(cm) 
1 15 0,5 17 
2 15 0,5 15 
3 15 1,0 15 
4 15 1,0 17 
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The fiber diameter, calculated using Imagej software, comparisons is presented in the 
Fig 11. 
 
Fig 11 - Fiber diameter variations for the different parameters used 
 
Through the analysis of the fibre diameter, one can conclude that the most suitable 
set of conditions is the one used in Conditions 1, as the average fiber diameter is in the 
range of those presented in the ECM [4]. Based on this data these were the chosen 
conditions. 
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Fig 12 - Flowchart of the production of pure PU and composite membranes 
 
 
3.4. Anti-bacterial assays 
The antibacterial essays were carried out according to the ASTM E2149 method, with 
respective modifications, named ‘’Determination of the Antibacterial activity of 
Antibacterial Agents immobilized under conditions of dynamic contact’’ [54].  
This is a sensitive method, and commonly used to measure the antibacterial activity of 
irregular or hydrophobic surfaces.  
The assays were carried out using the bacteria Escherichia Coli and Staphylococcus 
Aureus, due to the fact that both are well known and both are normally recommended as 
models for this type of tests [55].  
The procedure has a duration of 3 days and can be summarized in the following main 
steps: incubation of the bacterial culture, at 37ºC during at least 16h, addition of the 
bacterial suspension to a phosphate based buffer and, insertion of the PU or composite 
membranes to the buffer solution, followed by incubation under constant stirring for 1h; 
PU 
DMF:THF 
(1:1) 
Polymer solution 
(10% wt PU) 
PU/ZnO solution 
Mixing and Sonication 
Electrospinning: 
15,6 kV 
17cm 
0,5 mL/h 
PU/ZnO 
membrane 
ZnO 
Nanoparticles 
PU 
DMF:THF 
(1:1) 
Polymer solution 
(10% wt PU) 
Mixing and Sonication 
Electrospinning: 
15,6 kV 
17cm 
0,5 mL/h 
PU 
membrane 
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decimal dilutions of the incubated suspensions; superficial seeding on petri plaques; 
incubation during 16-24h at 37ºC and finally counting of the Colony Forming Unities 
(CFU). 
The tests with the PU/ZnO membranes, were started placing 1 sample (12 mm 
diameter each) of pure PU membrane and the membrane containing 50% ZnO content in 
1mL of bacterial suspension. This was made in order to establish a baseline. The 
concentration was gradually increased to 3 and then 5 samples (12 mm each) of each 
membrane. These concentrations were selected because in the membranes, the zinc 
oxide particles are dispersed in a polyurethane matrix which can attenuate the effects of 
the zinc oxide. 
 The detailed procedure of the essays for the determination of bacterial viability can 
be consulted in the Annexes. 
 
 
 
3.5. Characterization Techniques 
3.5.1. X-ray Diffraction (XRD) analysis 
XRD analysis is a powerful nondestructive technique that allows the identification of 
the crystalline phases of the material, such as lattice parameters, crystallite size and 
crystallographic orientation [56], [57]. This technique is based on the interaction of x-rays 
with the target surface and its diffraction into many specific direction. According to Bragg’s 
law (Fig 13), only favourably oriented atomic planes relatively to the incident radiation lead 
to constructive interferences of diffracted radiation [58], [59]: 
𝑛𝜆 = 2𝑑ℎ𝑘𝑙 sin Ѳ 
in which the ‘nλ’ is the constructive phase difference, ‘dhkl’ is the interplanar distance 
and ‘ϴ’ is the reflection angle between a crystallographic plane and the incident radiation 
with wavelength ‘λ’ (Fig 13) [56]. 
Through the variation of the diffraction angle, 2ϴ and measuring the intensity of the 
diffracted beam, which depends of the number of atomic planes evenly spaced, a 
diffractogram is obtained, which can be compared against a database to help identify the 
structure of the material [60]. 
The average crystallite size ‘D’ is related to the width of a peak in the x-ray in a scan 
from ϴ to 2ϴ diffraction and can be calculated using the Debye-Scherrer equation [61]: 
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𝐷 =
𝐾𝜆
𝛽 cos Ѳ
 
where λ is the wavelength, ϴ is the diffraction angle analysed K is the a factor (it 
assumes the value of 0.89 for spherical surfaces). β is defined as: 
𝛽 = √(𝐴𝑜𝑏𝑠
2 − 𝑎2) 
where Aobs refers to the width at half height of the sample peak being analyzed, and a 
refers to the width at half height of the peak of a standard sample.  
X-ray diffraction analysis was used to identify the crystalline phases compositions of 
the materials studied (precipitates and commercial zinc oxide powders, polyurethane, and 
PU/ZnO composites) and to calculate crystallite sizes (TC), through the Debye-Scherer 
equation.  
 
 
Fig 13 - Visual representation of Bragg's Law 
 
3.5.2. N2 Isotherm Analysis 
An adsorption isotherm curve represents the relation, at constant temperature 
between the quantity of the gas adsorbed at the surface of the material and the partial 
pressure at which it occurs. Usually it is represented as a quantity adsorbed in function of 
the relative pressure (p/pº), where p and pº are the pressure and the saturation pressure 
of the adsorbed substance at the assay temperature, respectively. The adsorption 
isotherm proposed by Braunauer, Emmet and Teller (BET isotherm) describes the gas 
adsorption on a material surface in four basic stages [62]. 
In the first stage the gas molecules adsorb at the material surface through Van der 
Waals forces. With the rise of pressure, more gas molecules adsorb till a complete 
monolayer is achieved (stage 2) and with the further increase of pressure new gas layers 
are formed (stages 3 and 4). 
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Currently, and accordingly to IUPAC, there are six types of classifications for the gas 
adsorption isotherms. (Fig 14) 
 
 
Fig 14 - IUPAC classification for gas adsorption isotherms 
 
 
Table 10 – Summary of the six types of isotherms 
Type I The Type 1 (also known as Langmuir isotherm) is 
characteristic of microporous solids with low external surface. It presents a 
baseline corresponding to the filling of the micropores and its height is 
related to the porous volume. 
Type II It is associated with non-porous materials where point B corresponds to 
monolayer formation. 
Type III This type of isotherm is not common and is associated with an energy 
adsorption lower than Type 2. 
Type IV Presented by mesoporous materials. 
Type V It occurs in micro and mesoporous materials, in which the adsorption is 
based on a weak gas / solid interaction. 
Type VI It is associated with non-porous uniform surfaces and translates a multilayer 
adsorption mechanism. 
 
 
The phenomenon of adsorption hysteresis occurs when the adsorption isotherm does 
not coincide with the desorption isotherm. According to the IUPAC classification, 
generally, four main hysteresis curves types are considered and are represented Fig 15. 
Each hysteresis cycle is associated to different pore structures [60]. 
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Fig 15 - Classification of hysteresis cycles (irreversible adsorption / desorption processes) according to 
IUPAC classifications 
 
Table 11 - Summary of different types of hysteresis 
 
 
3.5.3. Brunauer, Emmet and Teller (BET) Model 
The BET model, applied to the adsorption isothermals analysis, is used to determine 
the specific surface area of the nanoparticles [63]. The model assumes a dynamic 
equilibrium between adsorption and desorption, supposing that the adsorption can occur 
in multi-layer. The BET equation is used in a linear form [64]: 
𝑝
𝑝  ⃘
𝑛𝑎𝑑𝑠 (1 −
𝑝
𝑝  ⃘)
=
1
𝑛𝑚
𝑎 𝑐
+
𝑐 − 1
𝑛𝑚
𝑎 𝑐
𝑝
𝑝  ⃘
 
where p is the pressure at equilibrium, p  ⃘ is the saturation pressure at the adsorption 
temperature, 𝑛𝑎𝑑𝑠 is the adsorbed quantity at p pressure and 𝑛𝑚
𝑎  is is the amount 
adsorbed required to fill the monolayer. The c parameter is called the BET constant is 
given by: 
𝑐 = 𝑒(𝐸1−𝐸𝐿)/𝑅𝑇 
where E1 and EL represent the relative adsorption heat in the first layer and the heat of 
vapor condensation, respectively [62]. The area that a monolayer occupies at the surface 
H1 Presents two, almost, parallel branches and is associated to porous 
materials consisting of rigid agglomerates of spherical particles of uniform 
size. 
H2 Presents a vertical desorption branch and is associated to different 
mechanisms of condensation and evaporation in bottle-shaped pores 
(narrow neck and broad body). 
H3 Associated with aggregates of plate-shaped particles, causing slit pores. 
H4 Characterized by two almost horizontal and parallel branches and is 
associated with narrow slit pores 
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of the solid may be related to the amount adsorbed on the monolayer by the following 
expression: 
𝐴𝑆𝐸 = 𝑛𝑚
𝑎 𝑁𝐴𝑎𝑚 
where NA corresponds to the number of Avogadro and am is the mean area by one 
molecule of adsorbate in the monolayer. 
The specific surface area of nZnO was thus determined based on the physical 
adsorption of nitrogen gas, using the isotherm equation of Brunauer, Emmett and Teller 
(BET). 
In this study, a Micrometrics_Gemini 2370V5 equipment was used to measure the 
specific surface area of the zinc oxide produced powders. The samples were degassed at 
100ºC overnight in order to eliminate any gases or vapors adsorbed on the surface of the 
materials. 
 
3.5.4. Scanning Electron Microscopy (SEM) 
The principle of operation of Scanning Electron Microscopy is based on the 
bombardment of the surface of the material under study with a highly energetic electron 
beam (usually between 0.1 and 30 keV), resulting in the emission of electrons and 
photons. The electrons and photons emitted by the material will give rise to the image of 
the surface topography of the material [59]. 
Both the powders and the composites were characterized through SEM technique.  
The morphology of the composite membranes was observed through SU-70 Hitachi 
SEM. Samples for SEM can have any format, as long as they are supported by the 
sample holder. Normally, the samples are covered by a thin film of carbon or gold in order 
to give them electrical conductivity. 
All samples (pure PU membranes and composite membranes) were subjected to 
deposition of a thin carbon film on Emitech K950 equipment. 
In order to observe the samples, a small piece of carbon tape (Neubauer 
Chemikalien) was glued onto a flat aluminum sample holder. Subsequently, a very small 
amount of ZnO powder (2 to 3 mg) or composite membrane was placed on the adhesive 
tape.  
The diameters of the electrospun PU-ZnO fibers were, then measured using the 
micrographs obtained after SEM analysis with the help of ImageJ software. 
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3.5.5. Energy Dispersive Spectroscopy (EDS) 
The technique is commonly used for elemental and compositional analysis of the 
sample. It is based on the detection of secondary X radiation emitted by the sample as a 
result of the ionization of its atoms, due to its interactions with the incident electron beam 
that results in the ejection of electrons from one of the inner orbitals of the atoms (low 
energy levels) of the sample, leading to the formation of holes. To facilitate the return of 
the atom to its fundamental energy state, the electrons of the outermost orbitals (higher 
energy levels) tend to occupy the formed holes. The energy difference between these 
atomic levels leads to the emission of X radiation, which is collected by a suitable detector 
(dispersive energy spectrometer) thus allowing the identification and quantification of the 
constituent elements of the sample [65].  
The equipment used for SEM is sufficient to generate the electron beam required for 
EDS analysis. The X-ray detector used for EDS analysis is therefore normally integrated 
in SEM systems. The EDS method allows the rapid analysis of individual chemical 
elements of a sample by comparing the obtained spectrum with known X-ray energy 
values and element characteristics.  
 
3.5.6. Differential Thermal and Thermogravimetric Analysis (DTA/TG) 
The differential thermal analysis (DTA) aims to identify the nature of the reactions that 
occur during the material heating as well as to identify the temperatures at which the main 
transformations occur. The thermogravimetric (TG) analysis intends to investigate the 
mass variation of the material as a function of the temperature variation. In this work, 
these analyzes were performed on a Seteram Labsys 1600 DTA / TG-DSC equipment. 
For this purpose 10 mg of ZnO were placed in an alumina crucible and a heating rate of 
10 ° C min-1 was used. The analysis was carried out with an inert atmosphere of argon. 
In the present work, the technique was used to study the thermal behavior of the 
produced ZnO powders. 
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3.5.7. Mechanical Assays 
The mechanical properties of the PU-ZnO membranes were determined using a 
Shimadzu MMT-101N (Shimadzu Scientific Instruments, Kyoto, Japan) with a load cell of 
100N. The composite membranes were analysed via tensile tests. The tensile properties 
of the membranes were calculated through the analysis of the stress-strain curves taking 
into account the slope of the stress – strain curve at low strain (0-5%) Fig 16. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 16 - Graph used for the calculation of the tensile strength value, calculated through the 
slope of the trend line in the 0-3% range 
(%) 
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The essays were performed in triplicate, meaning that three stripes with a 3 cm 
length and a 1cm width were cut from each membrane sample. The stretched length, 
corresponding to the L0 was 1 cm. In Fig 17 we can see the schematics of the working 
apparatus. 
  
Fig 17 - Schematics of the used apparatus for testing the mechanical properties of the membranes 
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CHAPTER IV – RESULTS AND DISCUSSION 
 
4.1. Zinc Oxide Particles 
4.1.1. Crystal phase composition, shape and particle size 
The ZnO powders, produced by chemical precipitation were analyzed using XRD, 
SEM and BET. 
Fig 18 shows the X-ray diffractogram (XRD) of the ZnO samples studied in this work. 
The samples present a single hexagonal phase, with intense peaks, narrow and well 
defined indicating high crystallinity. According to ZnO crystal data sheet (file JCPDS 04-
008-8198) the diffraction peaks were indexed to the Wurtzite type hexagonal unit cell.  
Through this we can conclude that it is possible to produce ZnO nanoparticles using a 
chemical precipitation method, with the occurrence of a single crystalline phase. 
 
 
  
Fig 18 - XRD of the ZnO samples 
 
 
The intensity ratio of the XRD peaks corresponding to the planes (002) and (101), 
i.e
𝐼(002)
𝐼(101)
 ,is 0.46, 0.84 and 0.85 for commercial ZnO, nZnO1 and nZnO2, respectively. As 
these values are greater than the standard value for wurtzite ZnO (0.44), we can admit the 
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occurrence of different crystallographic orientations in both the powders produced via 
chemical precipitation  (nZnO1 and nZnO2)- with regard to the commercial ZnO powder 
[66].  
The crystallite sizes were determined by the Debye-Scherrer equation using the 
diffraction peak corresponding to the plane (101). The attained values were: 27; 23 and 72 
nm for nZnO1, nZnO2 and commercial ZnO, respectively. Among the sinthesized 
powders, nZnO1 is the one presenting better crystallinity as it has a crystallite size larger 
than nZnO2. 
SEM micrographs presented in Fig 19 and Fig 20 allow observing the differences in 
particle morphology of the ZnO powders under study. Regarding the commercial ZnO 
powders, large aggregates of ZnO particles with non-uniform morphology are observed, 
being well evident the large distribution of particle size, as large ZnO particles coexist with 
finer (nanometric) particles.  
 
 
Concerning the precipitated powders, they present a spherical urchin-like shape with 
an organized and complex structure which is composed of assembled ZnO nanoplates 
possessing an average thickness of 38 and 36 nm for nZnO1 and nZnO2, respectively Fig 
20. The measurements were performed on at least 2 micrographs taken in different 
regions of the sample and more than 30 nanoplates were measured in each micrograph. 
 
Fig 19 - SEM micrographs of the commercial ZnO powder 
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The information regarding the adsorption / desorption isotherms of the ZnO powders 
and the pore size distribution is presented in Fig 21 and Fig 23 
 
Fig 21 - Adsorption/ Desorption isotherms for different types of ZnO powders: a) commercial; b) nZnO1 
and c) nZnO2 
Fig 20 - SEM micrographs of the produced nZnO; a)nZnO1 b)nZnO2 
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According to IUPAC classification the adsorption/desorption isotherms of the 
commercial ZnO powder, which do not evidence a hysteric behavior can be classified as 
type II, typical of non-porous materials.  
Regarding the synthesized powders, the obtained curves can be classified as type IV 
isotherms (UIPAC), typical of mesoporous materials. The shape of the hysteresis curves 
(type H3 hysteresis) shown in the figure also indicates the presence of slit-like pores. This 
result is in line with the observations from SEM micrographs of both samples which 
suggest the presence of slit shape pores between the assembled ZnO nanoplates. 
 In agreement with the adsorption isotherms (Fig 21), the cumulative pore volume 
curves (Fig 22) showed differences between the zinc oxide powders: nZnO powders have 
a total pore volume of approximately 1.2x10-1cm3/g, which is substantially higher than the 
nZnO2 powder, whose total pore volume is approximately 6.0x10-2. 
 
 
Fig 22: Cumulative pore volume curves of the precipitated powders, nZnO1 and nZnO2 
 
The pore size distribution curves are also significantly different from each other 
although both powders present bimodal curves. The nZnO1 powder presents a relative 
maximum pore size of approximately 2.5 nm, high values of dV / dlog(w) can also be 
observed between 12.5 and 15.0 nm. As for the nZnO2 powder, the highest value of dV / 
dlog(w) is observed at around 12.5 nm, with an observable peak at 2.5 nm.  
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Fig 23 - Pore size distribution curves for the precipitated powders nZnO1 and nZnO2 
 
The specific surface areas (SSA) of nZnO1 and nZnO2 powders are 23.8 m2/g and 13 
m2/g respectively. It is reported in the literature that zinc oxide nanoparticles synthesized 
by chemical precipitation presented values of SSA of 21 m2/g, similar to those obtained for 
nZnO1 nanoparticles [67]. The pore size distribution curves of the precipitated powders 
show the importance of fine pores (aprox. 2.5 nm) to the porosity of the particle. 
These differences may reflect the processing parameters variation, such as the 
reagents mixing rate. In the case of nZnO1 the addition rate was of 18 mL/min while for 
nZnO2 the mixing rate was 13 mL/min. A higher addition rate means that a greater amount 
of reagent (the basic solution) is added per unit of time to the acidic one. It may be 
expected that such conditions provide a higher initial supersaturation which could result in 
a higher nucleation rate, that is, the formation of more nuclei, which would then lead to a 
larger number of smaller sized particles as compared to the case of nZnO2 [68], [69].  
 
 
The equivalent spherical diameter (ESD) was determined by [62]: 
𝐸𝑆𝐷 =
6
𝑆𝐹𝐴 × 𝜌
 
 
where ρ is the theoretical density of ZnO (5,6 g/cm3) 
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The values of ESD calculated for nZnO1 and nZnO2 are 45 nm and 82 nm, 
respectively. These results indicate that although the particles exhibit diameters in the 
order of microns (exceeding 100 nm which is the size limit normally accepted for “nano” 
classification), their surface areas are equivalent to particles with a spherical diameter of 
less than 72 nm, thus supporting the designation of nanoparticles or nanostructured 
particles. 
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4.1.2 ZnO Differential Thermal and Thermogravimetric Analysis 
 
The differential thermal analysis of the ZnO nanoparticles (Fig 24) revealed the 
presence of two endothermic peaks at around 100 and 200 ºC and an exothermic peak 
right before the 300º C. The peaks seem to be preceded by a loss in mass in the 
thermogravimetric curve, with the major weight loss occurring at around 250º C.  The 
major weight loss that occurs until the 100ºC mark may be due to the evaporation of 
water, or the removal of hydroxyl groups in the sample [70], [71]. There is another major 
weight loss between 220º and 500ºC could be due to the removal and decomposition of 
organic groups present in the sample during the synthesis. Furthermore there was no 
significant weight loss above 500º C, indicating that decomposition does not occur above 
this temperature and that the stable residues may be attributed to ZnO nanoparticles [72]. 
The high intensity peak at around 300º C is in agreement with the results found in the 
literature,  and is thermal event that can be associated with the a burn-out of organic 
composition [71], [73], [74].  
 
 
 
Fig 24 – DTA/TG graph of nZnO1 with a heating rate of 10ºC/min in an Argon atmosphere 
 
As can be seen in Fig 25 the heating of the nanoparticles is accompanied by a 
structural transformation, resulting from the fusion of the nanoplates due to the heating 
process which leads to a reduction in SSA.   
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Fig 25 - Structural modifications resulting from the heating process a)nZno1 subjected to 250ºC; b) 
nZnO1 subjected to 1000º C 
 
 
 
 
4.2. PU/nZnO1 membrane Characterization  
As previously mentioned, different membranes were produced with different 
concentrations of ZnO. The nZnO1 powder was chosen due to its high SSA.  The 
membranes analyzed in this study had a ZnO content of 10, 25 and 50% (zinc oxide mass 
/ total mass of the composite) and were denominated M-10, M-25 and M-50 respectively. 
The pure PU membrane was denominated M-0. 
The membranes were observed by SEM in order to analyze the type of deposition and 
dispersion of the ZnO nanoparticles. An EDS analysis (Fig 26) was also performed to 
assess the existence of contaminations. The high intensity peaks shown in the EDS 
confirm the presence of the ZnO particles in the PU matrix. Some C and Al traces are 
found in the spectrum coming from the coating and the sample holder. As no other signals 
were detected within the detection limits of the EDS it can be conclude that the nZnO 
particles have no contaminations. 
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The SEM observations, presented in Fig 27 and Fig 28  show samples of the different 
composite membranes, as well as a membrane composed of pure PU. The images are 
ordered from the pure PU membrane (a) to the membrane with the highest content in 
nZnO (d).The images show the presence of the ZnO nanoparticles in the PU membrane 
and it is perceptible the increase amount of nanoparticles in the membrane with higher 
ZnO concentration. The particles appear to be well dispersed throughout the PU matrix. 
Another important aspect that can be observed in the micrographs is the fact that the ZnO 
nanoparticles are either embedded in the fibers or entrapped in the matrix.  
Fig 26 – EDS analysis of the composite membrane  
78 
 
Fig 27 - SEM micrographs of the membranes for different nZnO1 concentrations; a) 0%; b)10%; c)25% 
and d)50% 
 
 
Fig 28 - SEM micrographs of the membranes for different nZnO1 concentrations with higher ampliation ; 
a) 0%; b)10%; c)25% and d)50% 
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The thickness of the membranes was also measured, using a micro meter instrument, 
as it was an important parameter for the tensile strength calculations. The results are 
presented in Table 12. Previous studies for small diameter blood vessel presented a wall 
thickness in the ranges of 160 to 930 µm for autologous grafts [75] and 250 µm for PU 
based grafts, as is the case of Matsuda et. al [29], who worked with commercially 
available PU and Williamson, who produced PCL-PU composite fibers [76]. 
When compared to these values the produced PU-nZnO1 composite membranes 
thickness falls a bit short, this could fixed by increasing the volume of the polymer 
solution, or further optimization of the electrospinning parameters, because as can be 
seen for Fig 28 some of the samples (a and c) present fused fibers. Although the 
electrospinning parameters were the same for all membranes, they have different 
thickness values, this may be due to external variables such as humidity and temperature, 
as these play an important role on the conductivity of the polymer solution.   
 
 
 
Table 12: Membrane thickness in function of ZnO percentage 
ZnO% Thickness 
(µm) 
0 50 
10 110 
25 70 
50 180 
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4.3. Antibacterial properties 
The antibacterial studies were performed on all membranes, as a way to evaluate the 
relation of increasing ZnO concentration and its impact on the antibacterial properties of 
the membrane. The antibacterial properties were tested on both E.coli and S.aureus using 
the method ASTM-2149 [43]. 
 
 
Antibacterial behavior of PU / nZnO1 membranes 
The results from both tests with 1 and 3 disks of each membrane indicated that the 
concentration of ZnO used was not enough to inflict antibacterial properties. The controller 
sample used showed more antibacterial activity than the membrane with highest nZnO1 
concentration.  
As a result the number of disks was increased to 5. 
In Fig 29 we can see the results regarding the 5 disk samples for each of the tested 
concentrations. As can be seen from the data, the results show that the higher the ZnO 
concentration, the higher the antibacterial activity. The maximum bacterial reduction 
(70.5%) was achieved for the 50% ZnO concentration.  
 
Fig 29 - Bacterial reduction for E.Coli in function of nZnO concentration in PU-nZnO1 composites 
81 
 
Fig 30 - Bacterial reduction for S.aureus in function of nZnO concentration in PU-nZnO1 composites 
 
 
The S.aureus assay showed an increase in bacterial reduction Fig 30 when compared 
with the results from the E.coli. 
For this essay all the parameters were maintained but the used bacterial strain. Once 
again we can see that bacterial reduction increases with the increase in ZnO 
concentration. The number of Colony Forming Units (CFU) was significantly reduced with 
the ZnO filled membranes. There are several mechanisms proposed regarding he 
antibacterial activity of ZnO nanoparticles, the release of Zn2+ions from the particles; 
mechanical destruction of the cell membrane caused by the penetrations of nanoparticles; 
active oxygen from the nanoparticles and the generation of hydrogen peroxide (H2O2) 
from the surface of ZnO [77]. 
The growth rate of a bacteria can be affected by the interactions with the 
nanoparticles in the membrane. As the nanoparticles used have a large surface area 
(23.8 m2/g) available for interactions, enhancing its antibacterial effect. The ZnO particles 
may increase the production of active oxygen, such as H2O2, and leading to cell death. It 
is assumed that H2O2 generated damages the cell membrane of bacteria, producing some 
type of injury, and inhibiting the growth of the cells or even killing them. The contact of the 
nanoparticles with the bacteria may disrupt its respirations, as they interact with the 
enzymes of the bacteria respiration chains, which in the case of the E.coli can account for 
as much as 87% of the total H2O2 production [44]. 
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It is reported in the literature that ZnO nanoparticles may interfere with the pumping 
activity of NorA protein of S. aureus [78]. The NorA protein mediates the active efflux of 
hydrophilic fluoroquinolones from the cell, conferring resistance upon the organism. recent 
reports suggest that nano-sized metal oxides such as zinc oxide and titanium dioxide 
possess the ability to induce faster electron transfer kinetics in the active site of the 
enzymes, based on this, it seems likely that ZnO nanoparticles may interfere with the 
pumping activity of the this protein. 
It is also possible that the polymer surfaces slightly degrade during incubation and 
some ZnO nanoparticles were released into the culture medium where they interfered with 
bacteria cell membranes. 
The difference in activity against these two types of bacteria can be attributed to the 
structural and chemical compositional differences of the cell surfaces. Gram-positive 
bacteria typically have one cytoplasmatic membrane and thick wall composed of 
multilayers of peptidoglycan. However, gram-negative bacteria have more complex cell 
wall structure, with a layer of peptidoglycan between outer membrane and a cytolasmatic 
membrane [79]. The antibacterial effect can be attributed to the damage of cell 
membranes, which leads to leakage of cell contents and cell death. Therefore, the 
difference in antibacterial action towards E.coli and S. aureus is assumed to be caused by 
the different sensitivities towards H2O2 generated by the ZnO nanoparticles [77]. 
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4.4. Mechanical Properties of the PU/ZnO membrane 
In this work ZnO nanoparticles were introduced in a PU matrix, and thus it becomes 
important to analyse the effect of nanoparticles in the mechanical properties of the PU 
based composites. 
The results for the tensile strength in function of the ZnO concentration are presented 
in Fig 31.  
It is important to mention that all the samples were stretched to 30% of their original L0 
and no visible signs of rupture were observed or registered.  
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Fig 31 - Tensile strenght value of the membranes in function of the nZnO concentration 
 
The data indicates that the highest tensile strength value was observed for the 10% 
concentration sample and that the increase of ZnO concentration reduces the tensile 
strength of the membrane. This may be due to the increase in nanoparticles content 
causing the increase of defects in the matrix [68]. 
These results seem to be in agreement with previous studies, although the obtained 
values are lower. It is important to mention that the previous studies used different 
nanoparticles structure and a different method for the production of the PU matrix, as Le 
et. al used commercially available ZnO and his composites were produced via solvent 
casting [43]. The overall results appear to be better that those of the small blood vessels, 
as the results from autologous grafts for small diameter blood vessels range from 58 kPa 
to 2.6 MPa [75], [80]. 
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CHAPTER V – CONCLUSIONS AND FUTURE WORK 
 
The present work was focused on the development of PU/ZnO composite membranes 
and its characterization in terms of microstructure, antibacterial and mechanical 
properties. Zinc oxide presents itself as a polyvalent material, suitable for various 
applications in the biomedical field, mainly due to its antibacterial properties. However, the 
mechanisms of the biocidal action of these nanostructures are far from being fully 
understood. 
A suitable way to make use of the zinc oxide antibacterial properties is by enveloping 
the nanoparticles in a polymer matrix, such as polyurethane. 
For this purpose, zinc oxide nanoparticles were synthesized by a method of chemical 
precipitation. Through the controlled variation of some experimental procedures (Cit:Zn 
ratio and addition rate) several nanostructured particles were obtained, presenting 
different characteristics, such as the specific surface area ( 23.8 m2/g for nZnO1 and 13 
m2/g for nZnO2). Both samples resulted from the agglomeration of nanometer-sized plates 
(nZnO1 presented plates with a mean thickness of 38 nm and nZnO2 presented plates 
with a mean thickness of 36 nm).  
Polyurethane composites with nZnO1 as a filler were also produced with zinc oxide 
contents of 10, 25 and 50% (zinc oxide mass/ PU mass) as well as a pure PU membrane. 
The studies of the antibacterial properties were performed against E.coli and 
S.aureus, and allowed to evaluate the antibacterial activity of the PU/nZnO1 composites 
for the different concentrations. It was concluded that the antibacterial properties of the 
composites is dependent on the ZnO content, the higher the content, the higher the 
observed bacterial reduction. 
The mechanical properties of the membranes were also tested and it was concluded 
that the tensile strength of the composites was increased, when compared to the pure PU 
membrane. The optimal content of nZnO1 was found to be 10%, as this was the value the 
presented the highest tensile strength. It was relevant the fact that none of the 
membranes has suffered any rupture during the assays. 
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Future Work 
The results obtained in the present work require the deepening of certain aspects in 
order to clarify some data. In this way it is suggested: 
 Use a higher volume of the polymer solution as a way to produce thicker 
membranes, and evaluate their overall behaviour; 
 Further optimization of the electrospinning conditions; 
 Quantify the reactive oxygen species produced by the ZnO nanoparticles as a 
way to better understand the antibacterial behaviour of the composite 
membranes; 
 Loading the composite membrane with a drug and trying to establish a 
controlled release. 
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Bacterial Viability Assay 
 
The experimental procedure for the determination of the bacterial viability was carried out 
in the course of 3 days and involves the following steps: 
Day 1: 
The TSB (Trypstic soy broth) and PCA (Plate count Agar) medium were prepared 
according to the manufacturer’s instructions. Both mediums were sterilized using an 
autoclave. 
The petri dishes (90 mm) were prepared with PCA culture medium. The plates were 
stored at 4ºC. the entire process was conducted under aseptic conditions in a laminar flow 
chamber and in the vicinity of a flame, so as to avoid contamination of the culture medium 
by microorganisms. 
The culture of E.coli was incubated in TSB at 37ºC under constant agitation (180 rmp) 
over night (16h) 
 
Day 2: 
The optical density of the bacterial culture, prepared the precious day, was read on a 
spectrophotometer with a 600 nm wavelength. A sample of TSB was used as blank. 
2 ml of bacterial culture were were washed by centrifugation, with replacement of the 
supernatant by phosphate buffer (pH=7.2 ). This procedure was repeated twice to ensure 
the removal of traces of culture medium. 
After that, the culture was resuspended in buffer using a volume which guarantees a 
concentration of bacteria of 2.4x109 cell/ ml. The volume of phosphate buffer used was 
determined based on the optical density measurements taken at the beginning of the 
procedure, assuming that one unity of optical density corresponds to a bacterial 
concentration of 8x108 cell/ ml. 
Meanwhile, 900 µl of buffer solution were placed inside microtubes alongside the 
membrane samples (disks with 12mm diameter), 2 ml microtubes were used to ensure 
that the membranes were not immobilized, guarantying a dynamic assay. 100 µL of the 
bacterial suspension were then added to each microtube. A microtube containing a known 
bacterial concentration (2.4x108 cell/mL) served as a control sample. 
Each of this microtubes were incubated under constant stirring for one hour at room 
temperature, after which decimal dilutions of each sample were made. For each decimal 
dilutions (designated -1, -2, -3, -4, -5) a microtube was prepared with 900 µL of the buffer 
solution and 100 µL of the incubated solution. 
99 
Finally, the culture plates were seeded, this consist of adding 100 µL of each decimal 
dilution to each plate. This was made in triplicate to calculate the mean and standard 
deviation. The inoculated plates were incubated overnight (16h) at a temperature of 37ºC 
(optimum temperature for E. coli growth). 
 
Day 3: 
The number of CFUs (Colony Forming Units) was counted on each plate. Counts 
performed on plates inoculated with the composite membrane and the pure PU 
membrane are compared with the count of the CFUs present in the controlled sample, 
thus allowing the determination of the reduction of bacterial viability, based on the 
following equation: 
𝑅 = 100 −
𝐶𝐹𝑈𝑝 × 100
𝐶𝐹𝑈𝑐
 
Where CFUp is the number of weighted Colony Forming Units in CFU/ mL, calculated as: 
𝐶𝐹𝑈𝑝 = 𝐶𝐹𝑈 × 𝑉 × 𝐹𝐷 
Where CFU is the count of the Colony Forming Units if an inoculated petri dish, V is the 
volume of the test suspension seeded on the plate (0.1 mL) and FD is the dilution factor. 
 
The table below shows the results used in Fig. 29 and Fig. 30. 
 
Table 13: Table with the CFU from the E.coli test 
Sample Dilution CFI Volume 
(ml) 
Dilution 
Factor 
Weighted CFU (CFU/ ml) Reduction 
(%) 
C -4 209 0.1 1.00E+04 2.09E+05 1.73E+05 
-4 175 0.1 1.00E+04 1.75E+05 
-4 135 0.1 1.00E+04 1.35E+05 
0% -4 134 0.1 1.00E+04 1.34E+05 22.5433526 
-4 38 0.1 1.00E+04 3.80E+04 38.03468208 
-4 92 0.1 1.00E+04 9.20E+04 46.82080925 
10% -4 66 0.1 1.00E+04 6.60E+04 61.84971098 
-4 89 0.1 1.00E+04 8.90E+04 48.55491329 
-4 103 0.1 1.00E+04 1.03E+05 40.46242775 
25% -4 85 0.1 1.00E+04 8.50E+04 50.86705202 
-4 71 0.1 1.00E+04 7.10E+04 58.95953757 
-4 73 0.1 1.00E+04 7.30E+04 57.80346821 
50% -4 68 0.1 1.00E+04 6.80E+04 60.69364162 
-4 53 0.1 1.00E+04 5.30E+04 69.36416185 
-4 51 0.1 1.00E+04 5.10E+04 70.52023121 
 
100 
 
 
 
Table 14: Table with the CFU from the S.aureus test 
Sample Dilution CFI Volume 
(ml) 
Dilution 
Factor 
Weighted CFU (CFU/ ml) Reduction 
(%) 
C -5 213 0.1 100000 2130000 2083333.333 
-5 183 0.1 100000 1830000 
-5 229 0.1 100000 2290000 
0 -4 162 0.1 10000 162000 92.22399876 
-4 192 0.1 10000 192000 90.78399853 
-4 209 0.1 10000 209000 89.96799839 
10% -4 84 0.1 10000 84000 95.96799935 
-4 69 0.1 10000 69000 96.68799947 
-4 63 0.1 10000 63000 96.97599952 
25% -4 42 0.1 10000 42000 97.98399968 
-4 71 0.1 10000 71000 96.59199945 
-4 62 0.1 10000 62000 97.02399952 
50% -4 85 0.1 10000 85000 95.91999935 
-4 61 0.1 10000 61000 97.07199953 
-4 73 0.1 10000 73000 96.49599944 
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